VISTAGEN THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $64.7M | $68.1M |
| FY2023 | — | $12.1M | $16.6M |
| FY2024 | — | $114.3M | $119.2M |
| FY2025 | — | $70.4M | $67.1M |
| FY2026 | — | $35.5M | $30.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $64.7M | $68.1M |
| FY2023 | — | $12.1M | $16.6M |
| FY2024 | — | $114.3M | $119.2M |
| FY2025 | — | $70.4M | $67.1M |
| FY2026 | — | $35.5M | $30.8M |